These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 30096384

  • 1. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction.
    Cheng C, Tan J, Qian W, Zhang L, Hou X.
    Life Sci; 2018 Sep 15; 209():157-166. PubMed ID: 30096384
    [Abstract] [Full Text] [Related]

  • 2. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
    Mouries J, Brescia P, Silvestri A, Spadoni I, Sorribas M, Wiest R, Mileti E, Galbiati M, Invernizzi P, Adorini L, Penna G, Rescigno M.
    J Hepatol; 2019 Dec 15; 71(6):1216-1228. PubMed ID: 31419514
    [Abstract] [Full Text] [Related]

  • 3. Escherichia coli NF73-1 disrupts the gut-vascular barrier and aggravates high-fat diet-induced fatty liver disease via inhibiting Wnt/β-catenin signalling pathway.
    Ke Z, Huang Y, Xu J, Liu Y, Zhang Y, Wang Y, Zhang Y, Liu Y.
    Liver Int; 2024 Mar 15; 44(3):776-790. PubMed ID: 38225740
    [Abstract] [Full Text] [Related]

  • 4. DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH.
    Gäbele E, Dostert K, Hofmann C, Wiest R, Schölmerich J, Hellerbrand C, Obermeier F.
    J Hepatol; 2011 Dec 15; 55(6):1391-9. PubMed ID: 21703208
    [Abstract] [Full Text] [Related]

  • 5. Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.
    Rahman K, Desai C, Iyer SS, Thorn NE, Kumar P, Liu Y, Smith T, Neish AS, Li H, Tan S, Wu P, Liu X, Yu Y, Farris AB, Nusrat A, Parkos CA, Anania FA.
    Gastroenterology; 2016 Oct 15; 151(4):733-746.e12. PubMed ID: 27342212
    [Abstract] [Full Text] [Related]

  • 6. DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model.
    Achiwa K, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Hirooka Y, Katano Y, Goto H.
    Biochem Biophys Res Commun; 2016 Jan 29; 470(1):15-21. PubMed ID: 26682925
    [Abstract] [Full Text] [Related]

  • 7. Gut inflammation exacerbates hepatic injury in C57BL/6J mice via gut-vascular barrier dysfunction with high-fat-incorporated meat protein diets.
    Hussain M, Umair Ijaz M, Ahmad MI, Khan IA, Bukhary SUF, Khan W, Hussain S, Hashmi MS, Li C.
    Food Funct; 2020 Oct 21; 11(10):9168-9176. PubMed ID: 33026380
    [Abstract] [Full Text] [Related]

  • 8. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
    Zhou D, Pan Q, Xin FZ, Zhang RN, He CX, Chen GY, Liu C, Chen YW, Fan JG.
    World J Gastroenterol; 2017 Jan 07; 23(1):60-75. PubMed ID: 28104981
    [Abstract] [Full Text] [Related]

  • 9. Colonic inflammation accelerates the progression of liver disease: A protective role of dipotassium glycyrrhizate.
    Fiaschini N, Negroni A, Palone F, Vitali R, Colantoni E, Laudadio I, Mancuso M, Cucchiara S, Stronati L.
    Dig Liver Dis; 2022 Aug 07; 54(8):1084-1093. PubMed ID: 34903499
    [Abstract] [Full Text] [Related]

  • 10. Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis.
    Lan T, Xu T, Fu Y, Jiang S, Liang X, Yu Z, Pan L, Rong X, Guo J.
    Front Endocrinol (Lausanne); 2022 Aug 07; 13():864703. PubMed ID: 35784533
    [Abstract] [Full Text] [Related]

  • 11. Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease.
    Mao JW, Tang HY, Zhao T, Tan XY, Bi J, Wang BY, Wang YD.
    Int J Clin Exp Pathol; 2015 Aug 07; 8(4):3648-58. PubMed ID: 26097546
    [Abstract] [Full Text] [Related]

  • 12. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis.
    Chiu CC, Ching YH, Li YP, Liu JY, Huang YT, Huang YW, Yang SS, Huang WC, Chuang HL.
    Nutrients; 2017 Nov 06; 9(11):. PubMed ID: 29113135
    [Abstract] [Full Text] [Related]

  • 13. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
    Wang W, Zhao J, Gui W, Sun D, Dai H, Xiao L, Chu H, Du F, Zhu Q, Schnabl B, Huang K, Yang L, Hou X.
    Br J Pharmacol; 2018 Feb 06; 175(3):469-484. PubMed ID: 29139555
    [Abstract] [Full Text] [Related]

  • 14. Mesenteric adipose tissue contributes to intestinal barrier integrity and protects against nonalcoholic fatty liver disease in mice.
    Wu Z, Tan J, Chi Y, Zhang F, Xu J, Song Y, Cong X, Wu N, Liu Y.
    Am J Physiol Gastrointest Liver Physiol; 2018 Nov 01; 315(5):G659-G670. PubMed ID: 29902065
    [Abstract] [Full Text] [Related]

  • 15. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.
    Barreyro FJ, Holod S, Finocchietto PV, Camino AM, Aquino JB, Avagnina A, Carreras MC, Poderoso JJ, Gores GJ.
    Liver Int; 2015 Mar 01; 35(3):953-66. PubMed ID: 24750664
    [Abstract] [Full Text] [Related]

  • 16. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
    Vitaglione P, Mazzone G, Lembo V, D'Argenio G, Rossi A, Guido M, Savoia M, Salomone F, Mennella I, De Filippis F, Ercolini D, Caporaso N, Morisco F.
    J Nutr Sci; 2019 Mar 01; 8():e15. PubMed ID: 31037218
    [Abstract] [Full Text] [Related]

  • 17. Magnesium isoglycyrrhizinate attenuates nonalcoholic fatty liver disease by strengthening intestinal mucosal barrier.
    Lai X, Zhou H, Wan Y, Kuang J, Yang Y, Mai L, Chen Y, Liu B.
    Int Immunopharmacol; 2024 Feb 15; 128():111429. PubMed ID: 38171057
    [Abstract] [Full Text] [Related]

  • 18. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M, Bukong TN, Csak T, Saha B, Park JK, Ambade A, Kodys K, Szabo G.
    J Transl Med; 2015 Jun 16; 13():193. PubMed ID: 26077675
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D, Nistal E, Martínez-Flórez S, Pisonero-Vaquero S, Olcoz JL, Jover R, González-Gallego J, García-Mediavilla MV, Sánchez-Campos S.
    Free Radic Biol Med; 2017 Jan 16; 102():188-202. PubMed ID: 27890642
    [Abstract] [Full Text] [Related]

  • 20. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
    Bae CR, Hino J, Hosoda H, Miyazato M, Kangawa K.
    Life Sci; 2018 Sep 15; 209():349-356. PubMed ID: 30114411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.